A Trial of Lopinavir-Ritonavir in Covid-19
N Engl J Med
.
2020 May 21;382(21):e68.
doi: 10.1056/NEJMc2008043.
Epub 2020 May 5.
Author
Kurt M Kunz
1
Affiliation
1
University of Pennsylvania, Philadelphia, PA kkunz@sas.upenn.edu.
PMID:
32369282
DOI:
10.1056/NEJMc2008043
No abstract available
Publication types
Letter
Comment
MeSH terms
Adult
Betacoronavirus
COVID-19
COVID-19 Drug Treatment
Coronavirus Infections / drug therapy
Humans
Lopinavir
Pandemics
Pneumonia, Viral*
Ritonavir*
SARS-CoV-2
Substances
Lopinavir
Ritonavir